Abstract:
Abstract.
Introduction. Non-Hodgkin’s lymphoma is a group of
malignant tumors that develop from hematopoietic cells
located outside the medullary. They are one of the most
common forms of hemoblastosis. Non-Hodgkin lymphoma
develops in people of all ages. Morbidity of non-Hodgkin
lymphoma increases with age reaching its highest level in
people over 50 years of age.
Material and methods. A study was carried out through
a narrative review of the literature in the form of a synthesis
article. The article summarized and systematized various
primary studies, dedicated to the epidemiological and diagnostic aspects of aggressive extranodal NHL.
Results. Aggressive extranodal NHL remains a major
problem, with a fairly large increase in incidence globally.
This trend is observed in several countries of the world,
thus morbidity increases by 3% annually for women and by
4% for men. Globally, aggressive non-Hodgkin’s lymphoma
continues to affect the working-age population. Although
patients with primary extranodal NHL tend to report to a
medical specialist at a lower stage than those with primary ganglion disease, the number of those addressing in advanced stages continues to be increased.
Conclusions. Although diagnosing NHL does not involve
great impediments, primary care physicians often detect
patients in the late stages of the disease either because of
delayed referral to the doctor or because of incorrect diagnosis. Despite the development of new methods of diagnosis and treatment, aggressive extranodal NHL continues to
be a current problem of clinical medicine and public health,
requiring increased managerial and financial efforts.
